Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Radiation × Clear all

NCT03247712 2025-07-10

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms